BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28184936)

  • 21. Chrysin inhibits metastatic potential of human triple-negative breast cancer cells by modulating matrix metalloproteinase-10, epithelial to mesenchymal transition, and PI3K/Akt signaling pathway.
    Yang B; Huang J; Xiang T; Yin X; Luo X; Huang J; Luo F; Li H; Li H; Ren G
    J Appl Toxicol; 2014 Jan; 34(1):105-12. PubMed ID: 24122885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined inhibition of EGFR and c-ABL suppresses the growth of triple-negative breast cancer growth through inhibition of HOTAIR.
    Wang YL; Overstreet AM; Chen MS; Wang J; Zhao HJ; Ho PC; Smith M; Wang SC
    Oncotarget; 2015 May; 6(13):11150-61. PubMed ID: 25883211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
    Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
    Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rab1A promotes cell proliferation and migration by upregulating Gli1 in colorectal cancer.
    Peng C; Li X; Ye Z; Wu W
    Sci Rep; 2021 Aug; 11(1):16243. PubMed ID: 34376787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-127 is downregulated by Tudor-SN protein and contributes to metastasis and proliferation in breast cancer cell line MDA-MB-231.
    Zhao X; Duan Z; Liu X; Wang B; Wang X; He J; Yao Z; Yang J
    Anat Rec (Hoboken); 2013 Dec; 296(12):1842-9. PubMed ID: 24155205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells.
    Janaki Ramaiah M; Lavanya A; Honarpisheh M; Zarea M; Bhadra U; Bhadra MP
    Gene; 2014 Dec; 552(2):255-64. PubMed ID: 25261849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
    Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
    Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lapatinib increases motility of triple-negative breast cancer cells by decreasing miRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6.
    Hsiao YC; Yeh MH; Chen YJ; Liu JF; Tang CH; Huang WC
    Oncotarget; 2015 Nov; 6(35):37965-78. PubMed ID: 26513016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of Rab1A is upregulated in human lung cancer and associated with tumor size and T stage.
    Wang X; Liu F; Qin X; Huang T; Huang B; Zhang Y; Jiang B
    Aging (Albany NY); 2016 Nov; 8(11):2790-2798. PubMed ID: 27902464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A soluble form of GAS1 inhibits tumor growth and angiogenesis in a triple negative breast cancer model.
    Jiménez A; López-Ornelas A; Estudillo E; González-Mariscal L; González RO; Segovia J
    Exp Cell Res; 2014 Oct; 327(2):307-17. PubMed ID: 24992044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
    Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OCT4 regulates epithelial-mesenchymal transition and its knockdown inhibits colorectal cancer cell migration and invasion.
    Dai X; Ge J; Wang X; Qian X; Zhang C; Li X
    Oncol Rep; 2013 Jan; 29(1):155-60. PubMed ID: 23076549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in Mahlavu cells.
    Tai CJ; Chin-Sheng H; Kuo LJ; Wei PL; Lu HH; Chen HA; Liu TZ; Liu JJ; Liu DZ; Ho YS; Wu CH; Chang YJ
    Ann Surg Oncol; 2012 Jan; 19(1):336-43. PubMed ID: 21516372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rab1A is an mTORC1 activator and a colorectal oncogene.
    Thomas JD; Zhang YJ; Wei YH; Cho JH; Morris LE; Wang HY; Zheng XF
    Cancer Cell; 2014 Nov; 26(5):754-69. PubMed ID: 25446900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
    J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-655-3p inhibited proliferation and migration of ovarian cancer cells by targeting RAB1A.
    Zha JF; Chen DX
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3627-3634. PubMed ID: 31114987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways.
    Ahmad A; Wang Z; Kong D; Ali R; Ali S; Banerjee S; Sarkar FH
    Breast Cancer Res Treat; 2011 Feb; 126(1):15-25. PubMed ID: 20379844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells.
    Szarc vel Szic K; Op de Beeck K; Ratman D; Wouters A; Beck IM; Declerck K; Heyninck K; Fransen E; Bracke M; De Bosscher K; Lardon F; Van Camp G; Vanden Berghe W
    PLoS One; 2014; 9(2):e87850. PubMed ID: 24498382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leptin receptor maintains cancer stem-like properties in triple negative breast cancer cells.
    Zheng Q; Banaszak L; Fracci S; Basali D; Dunlap SM; Hursting SD; Rich JN; Hjlemeland AB; Vasanji A; Berger NA; Lathia JD; Reizes O
    Endocr Relat Cancer; 2013 Dec; 20(6):797-808. PubMed ID: 24025407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity.
    Ferrari-Amorotti G; Chiodoni C; Shen F; Cattelani S; Soliera AR; Manzotti G; Grisendi G; Dominici M; Rivasi F; Colombo MP; Fatatis A; Calabretta B
    Neoplasia; 2014 Dec; 16(12):1047-58. PubMed ID: 25499218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.